MedPath

Diazepam

DIAZEPAM INJECTION, USP

Approved
Approval ID

a14f5930-a3ac-4996-9778-df5baa3d0bab

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 24, 2025

Manufacturers
FDA

Natco Pharma USA LLC

DUNS: 079590418

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

DIAZEPAM

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69339-136
Application NumberANDA210363
Product Classification
M
Marketing Category
C73584
G
Generic Name
DIAZEPAM
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateApril 24, 2025
FDA Product Classification

INGREDIENTS (6)

DIAZEPAMActive
Quantity: 10 mg in 2 mL
Code: Q3JTX2Q7TU
Classification: ACTIB
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EU
Classification: IACT
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
BENZOIC ACIDInactive
Code: 8SKN0B0MIM
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Diazepam - FDA Drug Approval Details